Yet another Schizo and MDD drug approved by FDA this week in an already crowded market. Inspiring to see that SOME companies out there know how to launch a drug with multiple indications at the starting line! Why didn't we do that??? Impressive AE profile and efficacy data versus Latuda...with the only exception being weight gain for Rexulti http://www.businesswire.com/news/home/20150710005794/en/U.S.-FDA-Approves-Otsuka-Lundbeck%E2%80%99s-REXULTI%C2%AE-Brexpiprazole#.VaRUePlVhBc
I'm sure managed will be lining up to pay for a dumbed down/expensive version of generic abilify. Hope that helps!. Don't worry about us, in 2 years we will all be on the street looking for a new job
Lundbeck trying to low ball reps to sell brexpeprizole. Unless a rep is unemployed, most will not accept their low offers.
Yes doctor, its just like Abilify only it causes a little more weight gain. Oh and insurance doesn't cover it. Good luck with this.